Young at Heart: Pioneering Approaches to Model Nonischaemic Cardiomyopathy with Induced Pluripotent Stem Cells.

Stem Cells Int · 2016 · PMC4823509 · PMID 27110250

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

The prevalence of NICM in patients enrolled in heart failure trials ranged from 19% to 53%; however, there may be significant bias in this data as other reports show much lower levels in unselected patient populations with greater gender balance [ 2 ].

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.